Alexandria Real Estate Equities (ARE) is down about 3% in Friday trading as another round of analyst expectation resets and price-target trimming keeps pressure on life-science office REIT valuations. The latest chatter centers on ongoing oversupply and slower demand for lab space, alongside the market’s sensitivity to interest rates and refinancing costs for leveraged real estate owners. (defenseworld.net)

Beyond sentiment, investors continue to focus on near-term leasing risk: the company has highlighted key lease expirations aggregating about 1.2 million rentable square feet with a weighted-average lease expiration date in April 2026 and roughly $71 million of annual rental revenue tied to that roll. Any softness in renewals or backfilling could keep occupancy and same-property performance under pressure. (morningstar.com)

Alexandria has been leaning on dispositions and partial-interest sales as a key 2026 financing lever, while also targeting lower leverage over time. That strategy gained urgency after the company cut its quarterly dividend to $0.72 per share (a 45% reduction) to conserve capital, a move that still weighs on income-focused REIT sentiment and keeps the stock trading as a “show-me” story into 2026. (investor.are.com)